RC
MDGL icon

Roundview Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History

Roundview Capital’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-603
Closed -$5K – 188
2016
Q2 		$5K Hold
603
– – ﹤0.01% 172
2016
Q1 		$5K Hold
603
– – ﹤0.01% 174
2015
Q4 		$7K Hold
603
– – ﹤0.01% 162
2015
Q3 		$37K Sell
603
-228
-27% -$16.5K 0.02% 155
2015
Q2 		$65K Sell
831
-343
-29% -$28.8K 0.02% 153
2015
Q1 		$80K Buy
1,174
+571
+95% +$49K 0.03% 148
2014
Q4 		$56K Hold
603
– – 0.02% 146
2014
Q3 		$64K Hold
603
– – 0.03% 126
2014
Q2 		$86K Hold
603
– – 0.03% 148
2014
Q1 		$91K Hold
603
– – 0.04% 124
2013
Q4 		$111K Hold
603
– – 0.05% 127
2013
Q3 		$133K Hold
603
– – 0.07% 118
2013
Q2 		$105K Buy
+603
New +$157K 0.07% 107

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return